Neurology in Wisconsin

Standard Imaging, Inc. is a manufacturer of radiation calibration and quality assurance instruments for medical physics and radiation therapy applications. Founded in 1989 and headquartered in Middleton, Wisconsin, the company specializes in precision dosimetry solutions, detectors, phantoms, and QA software for cancer treatment centers and diagnostic imaging facilities. Their product portfolio includes electrometers, Exradin scintillation and ionization chambers, water phantoms, and comprehensive QA systems for daily, monthly, and annual quality assurance protocols across linear accelerators, stereotactic radiosurgery systems, CT/CBCT scanners, and diagnostic imaging equipment. Standard Imaging's instruments are utilized in 98 of the top 100 U.S. cancer treatment centers and distributed across 80+ countries. The company emphasizes NIST-traceable absolute dosimetry, patient dosimetry solutions, and regulatory compliance (TG-142 standards). They also provide calibration services, inspection and testing, and software licensing agreements supporting clinical workflow optimization and uncompromising measurement precision.

Ad-Tech Medical Instrument Corporation is the world leader in electrode devices for neurological diagnostics and therapeutic applications. The company specializes in long-term EEG monitoring, brain mapping, stereoelectroencephalography (SEEG), and brain stimulation, primarily for surgical evaluation and treatment of intractable epilepsy and other neurological disorders. Ad-Tech's proprietary product portfolio includes subdural strip and grid electrodes, dual-sided subdural electrodes, depth electrodes with micro contacts, foramen ovale electrodes, intraoperative electrodes, spinal electrodes, electrode placement kits, accessory placement devices, and brain biopsy needles. The company is known for field-proven designs incorporating advanced materials and components, with emphasis on ease of use and proprietary connection systems. Devices are indicated for long-term monitoring up to 29 days. Ad-Tech was acquired by Nihon Kohden in a strategic move to strengthen comprehensive epilepsy diagnostics and care capabilities. The company serves surgeons, specialists, researchers, and neurosurgical centers globally, primarily through distributor networks. Founded in 1985, Ad-Tech maintains manufacturing and distribution operations from its Wisconsin headquarters.

Nexstim Plc manufactures navigated transcranial magnetic stimulation (nTMS) and repetitive TMS (rTMS) systems for clinical diagnosis, surgical planning, and therapeutic applications. The company's primary products are the SmartFocus® nTMS and NBS System platforms, which use 3D imaging and image-guided navigation to precisely target and quantify the electric field dose delivered to the brain. Clinical applications include motor and language mapping for presurgical planning in neurosurgery and epilepsy, treatment of major depressive disorder (FDA cleared), obsessive-compulsive disorder (OCD; FDA cleared as of 2026), and post-operative rehabilitation for spinal cord injury and complex regional pain syndrome (CRPS). The systems are used in academic medical centers, children's hospitals, and specialized neurosurgery and psychiatry clinics worldwide. Nexstim holds FDA 510(k) clearances and CE/MDR certification for multiple therapeutic indications. The company serves neurosurgeons, neuroradiologists, epileptologists, psychiatrists, and rehabilitation specialists. The technology integrates real-time neurophysiological feedback (motor evoked potentials, MEP recording) with anatomical imaging to guide clinical decision-making and optimize patient outcomes.

BioRESEARCH, Inc. is a dental and medical device manufacturer specializing in precision biometric equipment for functional dentistry, temporomandibular joint (TMJ) assessment, and neuromuscular evaluation. The company develops advanced diagnostic and therapeutic technologies that measure objective biometric data to support clinical decision-making in dental, orthopedic, and otolaryngologic applications. Key product lines include the BioEMG III, an advanced surface electromyography system for muscle activity recording and neuromuscular assessment; BioJVA (Joint Vibration Analysis), a non-invasive TMJ screening tool measuring vibration patterns during jaw movement; and the JT-3D Jaw Tracker, which provides high-precision 3D mandibular kinesiography with incisor-point path analysis. The company also distributes complementary diagnostic tools such as the T-Scan NOVUS for occlusal force analysis and the GMI NARIS for acoustic rhinometry and rhinomanometry in nasal airway assessment. Therapeutic offerings include the QuadraTENS (dual-channel ULF-TENS for muscle relaxation), M-Scan (portable surface electromyography), MLS Laser Therapy systems, and DEKA CO₂ lasers for soft-tissue procedures. All devices integrate with BioRESEARCH's BioPAK software platform for data analysis, interpretation, and patient management. The company serves general dentists, prosthodontists, orthodontists, sleep medicine practitioners, and otolaryngologists. Products are designed for clinical integration with real-time biofeedback, objective data capture for diagnosis and treatment monitoring, and enhanced patient communication and case acceptance. BioRESEARCH provides comprehensive continuing education courses covering Total BioPAK Interpretation (TBI), advanced TMD applications, and practice integration. Customer support includes an AI-powered chatbot (BioBOT) for device operation and software questions.

Accuray Incorporated is a global leader in radiation oncology and radiosurgery systems. The company manufactures advanced treatment platforms designed to deliver precise radiation therapy across a full spectrum of patient needs, with 479+ systems installed in 33+ countries. Accuray's primary product lines include the CyberKnife® S7™, a robotic stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT) system featuring AI-driven real-time motion synchronization for tumor treatment anywhere in the body, and the Radixact® system, which combines integrated 3D kVCT and megavoltage CT (MVCT) imaging for image-guided intensity-modulated radiation therapy (IG-IMRT) and 3D conformal radiation therapy (3DCRT). Both systems are designed to improve treatment precision, reduce workflow complexity, and enhance patient outcomes. Accuray serves oncology centers, hospitals, and specialized radiotherapy facilities globally. The company emphasizes quality of care, efficiency of workflow, and clinician confidence through continuous innovation. Over 31% of system components are sourced from U.S. suppliers. Accuray supports its installed base through comprehensive training programs, the AEx® peer community platform for user education and experience-sharing, and dedicated service and reimbursement support. The company operates in the high-stakes cancer treatment market, addressing complex cases including prostate, lung, brain, and other tumor types.

Natus Medical Incorporated is a leading provider of neurodiagnostic and sensory assessment solutions serving hospitals, clinics, and research facilities. The company specializes in electroencephalography (EEG), electromyography (EMG), nerve conduction studies (NCS), and evoked potential (EP) technologies for diagnosing and monitoring brain, nerve, and muscle disorders. Core product portfolio includes the UltraPro S100 EMG/NCS/EP system, NeuroWorks EEG software for routine, ambulatory, and ICU monitoring, and BrainWatch, a wireless point-of-care EEG platform for emergency and intensive care settings. Additionally, Natus operates a separate sensory division (natussensory.com) offering hearing and balance assessment, vision screening, and newborn care solutions. With over 80 years of industry experience, the company delivers integrated hardware, software, and data management platforms alongside comprehensive service, support, and clinical education through Natus Academies. Products are designed with clinician input to streamline workflows in routine EEG, long-term monitoring, ICU applications, and research studies. The organization positions itself as a comprehensive neurodiagnostic partner, supporting screening, diagnosis, treatment, and management of neurological and sensory conditions across care settings.